Jan 10, 2023

Dr. Tadd Lazarus is the Chief Medical Officer at Pictor, working on innovative diagnostic tests to provide answers to complicated clinical questions concerning the status of a patient's level of antibodies. From one specimen, their test can determine if the antibodies have been produced as a result of vaccinations or boosters and if the patient had the disease being tested for.  Their mission is to help patients determine if they have effective antibody levels and are able to have the kind of response that will be protected them over time.

Tadd explains, "We develop innovative diagnostic solutions to enable more informed clinical decisions both in human and animal health. Specifically, we have a highly multiplexed platform that really changes the way antibodies are detected. As we know from COVID, antibodies are proteins that our body manufactures in response to infectious agents, except we detect them differently. We detect antibodies in an incredibly focused and what we call highly multiplexed manner, so that we have an incredibly sensitive and specific test. But moreover, it's able to detect multiple antibodies that the body produces for multiple infectious agents at one time. That's a very big change."

"One of the reasons why it is important to determine if vaccinations and boosters are effective is that there are antibodies that can be administered to patients intravenously if those patients are determined not to have a clinically significant antibody response to vaccinations/boosters and/or infection. And those formulations are getting tweaked now for more predominant strains, so making sure that they're covered. So there's something that we can do about that for the immunosuppressed, the elderly, and the immunocompromised, who are not showing a healthy and protective antibody response."

@PictorLtd #pictor #PictArray #IVD #Biotech #Innovative #HumanHealth #COVID #Antibodies #AntibodyTest #ImmuneSystem

PictorDX.com

Listen to the podcast here